Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Krystal Biotech

Start price
Target price
Perf. (%)
€144.30
29.05.24
-
29.06.24
21.79%
30.06.24

buy
Immunic Inc.

Start price
Target price
Perf. (%)
€1.02
20.01.24
€2.50
30.06.24
3.24%
30.06.24

Could be very worthwhile Investment >20% year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€6.87
29.06.23
-
29.06.24
72.34%
30.06.24

buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€3.50
28.06.23
€3.00
28.06.24
-53.91%
28.06.24

buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.13
07.04.24
-
07.04.25
-17.73%
26.06.24

buy
Evolus Inc

Start price
Target price
Perf. (%)
€12.20
05.05.24
-
28.03.25
-18.85%
26.06.24

Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.30
25.06.23
-
25.06.24
-46.03%
26.06.24

Genocea Biosciences Inc.

Start price
Target price
Perf. (%)
€0.009
25.06.23
-
25.06.24
-
26.06.24

buy
Natural Alternat.

Start price
Target price
Perf. (%)
€6.70
25.06.23
-
25.06.24
-14.18%
26.06.24

Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€0.11
25.06.23
-
25.06.24
13.16%
26.06.24

Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.29
25.06.23
-
25.06.24
-21.77%
26.06.24

buy
Trinity Biotech ADR

Start price
Target price
Perf. (%)
€0.88
25.06.23
-
25.06.24
-51.54%
26.06.24

Merrimack Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.98
24.06.23
-
24.06.24
-
25.06.24

Novavax Inc.

Start price
Target price
Perf. (%)
€6.12
24.06.23
-
24.06.24
111.24%
25.06.24

buy
Acorda Therapeutics Cdt

Start price
Target price
Perf. (%)
€0.47
24.06.23
-
24.06.24
-
25.06.24

Medigene AG

Start price
Target price
Perf. (%)
€1.87
24.06.23
€1.00
24.06.24
-36.73%
25.06.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€1.06
24.06.24
-
24.06.25
72.61%
24.06.24

buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€1.06
24.06.24
-
24.06.25
72.61%
24.06.24

Capable Management
Good culture
Could be worthwhile Investment >10% per year
Few uniques
buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€2.25
24.06.24
-
-15.73%
24.06.24

Insmed Inc.

Start price
Target price
Perf. (%)
€47.00
28.05.24
-
28.05.25
36.17%
23.06.24

buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€3.15
28.05.24
-
28.05.25
-28.57%
23.06.24

buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.02
27.11.23
-
27.11.24
77.37%
23.06.24

Risky Investment
buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€2.88
10.06.24
-
10.06.25
-21.82%
23.06.24

buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.11
30.04.24
-
15.04.25
-27.03%
22.06.24

ImmunityBio Inc.

Start price
Target price
Perf. (%)
€5.99
27.05.24
-
27.05.25
16.15%
22.06.24